GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials - PubMed
7 hours ago
- #weight loss
- #GLP-1 agonists
- #obesity
- GLP-1 receptor agonists significantly increase the likelihood of weight loss compared to placebo.
- Tirzepatide and semaglutide ranked highest in efficacy among GLP-1-based agents.
- The study analyzed 21 randomized controlled trials involving 7024 participants.
- 78.54% of participants on GLP-1 agents achieved weight loss vs. 26.53% on placebo.
- The findings support GLP-1-based therapy as effective for clinical obesity management.